INS and fatty liver disease: The high expression of METTL3 and low expression of TYHDF2 in the liver of T2D increased the mRNA stability of Fasn, Acc1, and Srebp-1c, leading to hepatic steatosis and further reducing organ insulin sensitivity (79, 81, 91).